Drug Profile
Budesonide inhalation solution - Verus Pharmaceuticals
Alternative Names: Captisol-enabled budesonide inhalation solution - Verus PharmaceuticalsLatest Information Update: 19 Dec 2021
Price :
$50
*
At a glance
- Originator Verus Pharmaceuticals
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antivirals; Glucocorticoids; Pregnenediones; Small molecules
- Mechanism of Action Beta-adrenergic receptor agonists; Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Asthma
Most Recent Events
- 28 May 2019 No recent reports of development identified for clinical-Phase-Unknown development in Asthma in United Kingdom (Inhalation)
- 28 May 2019 No recent reports of development identified for research development in Asthma in USA (Inhalation)
- 14 Aug 2017 Chemical structure information added